scholarly journals A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer

1996 ◽  
Vol 73 (2) ◽  
pp. 210-216 ◽  
Author(s):  
I Adachi ◽  
T Watanabe ◽  
S Takashima ◽  
M Narabayashi ◽  
N Horikoshi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Late Phase ◽  
Recurrent Breast Cancer ◽  
Recurrent Breast

A multicenter phase II study of S-1 combined with irinotecan (CPT-11) for patients with advanced/recurrent breast cancer.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e11528-e11528
Author(s):  
U. Toh ◽  
N. Iwakuma ◽  
H. Otsuka ◽  
M. Takenaka ◽  
E. Ogo ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Recurrent Breast Cancer ◽  
Multicenter Phase ◽  
Recurrent Breast

A Multicenter Phase II Study of Docetaxel 60 mg/m2 as First-Line Chemotherapy in Patients with Advanced or Recurrent Breast Cancer

Breast Cancer ◽  
2004 ◽  
Vol 11 (4) ◽  
pp. 374-379 ◽  
Author(s):  
Takashi Ishikawa ◽  
Satoru Shimizu ◽  
Masaaki Inaba ◽  
Taro Asaga ◽  
Kiyohumi Katayama ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Recurrent Breast Cancer ◽  
First Line ◽  
Multicenter Phase ◽  
Recurrent Breast ◽  
Line Chemotherapy

scholarly journals An Exploratory Phase II Study of Eribulin Re-challenge After Short Term Therapy of 5-Fluorouracil for HER2 Negative, Advanced or Recurrent Breast Cancer

2021 ◽  
Vol 41 (10) ◽  
pp. 5007-5014
Author(s):  
TSUTOMU TAKASHIMA ◽  
SHIGEHIKO NISHIMURA ◽  
HIDEMI KAWAJIRI ◽  
YOKO MIZUYAMA ◽  
TAKEO NISHIMORI ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Recurrent Breast Cancer ◽  
Term Therapy ◽  
Short Term ◽  
Short Term Therapy ◽  
Recurrent Breast
Sign in / Sign up

Export Citation Format

Share Document